Combination therapy with ARBs and Beta-blockers for post-PCI patients with hypertension-Expert Opinion of Indian Cardiologists Dr Jeegar Dattani4 Jun 2024 11:00 AM ISTThe expert opinion is the first of its kind, guiding Indian Cardiologists in managing hypertension in post-PCI patients with comorbidities. A total of...
Unlocking the Potential: Germinated brown and black rice show promise for managing type 2 diabetes with dyslipidemia in new research Medha Baranwal4 Jun 2024 9:45 AM ISTChina: In the ongoing quest to manage type 2 diabetes mellitus (T2DM) and its comorbidities, researchers have turned their attention to the potential...
Bariatric surgery cuts use of medications for hypertension, diabetes and dyslipidemia, suggests study Dr. Shravani Dali20 April 2024 7:30 AM ISTBariatric surgery cuts use of medications for hypertension, diabetes and dyslipidemia, suggests study published in the Surgery for Obesity and Related...
Recent trends in epidemiology of dyslipidemias in India: Key takeaways Medha Baranwal27 Feb 2024 7:17 PM ISTIndia: A recent study published in the Indian Heart Journal has shed light on the trends in the epidemiology of dyslipidemias in India.Dyslipidemia is...
Extended use of inclisiran safe and efficacious among refractory dyslipidemia in patients with increased CV risk Dr Riya Dave29 Dec 2023 8:45 PM ISTA recent study sheds light on the safety profile of inclisiran, an innovative agent designed to reduce low-density lipoprotein cholesterol (LDL-C)....
Study finds no Direct Association Between Cholesterol Intake and Chronic Kidney Disease Risk Dr Riya Dave21 Dec 2023 11:15 AM ISTA recent investigation exploring the link between cholesterol intake and the risk of chronic kidney disease (CKD) has yielded intriguing insights,...
Vitamin D supplementation beneficial in managing dyslipidemia Aditi15 Nov 2023 2:00 AM ISTVitamin D supplementation benefits lipid profile and is beneficial as a dietary intervention for managing dyslipidemia, says Nima Radkhah and...
Longer the duration of HRT in women greater the risk of nonarteritic anterior ischemic optic neuropathy Niveditha Subramani7 Aug 2023 8:00 PM ISTNon-arteritic anterior ischemic optic neuropathy (NAION) is a condition caused due to impaired circulation of blood to the front of the optic nerve....
Obicetrapib addition to statins and ezetimibe safe and effective for LDL-C reduction and ASCVD prevention Medha Baranwal16 Jun 2023 11:15 AM ISTUSA: Obicetrapib could be used safely in high-intensity statin and ezetimibe in patients with elevated LDL-C (low-density lipoprotein-cholesterol),...
Combo of obicetrapib plus ezetimibe effective adjunct therapy for dyslipidemia patients Dr. Kamal Kant Kohli7 Jun 2023 11:15 AM ISTUSA: A recent study has highlighted the potential of obicetrapib plus ezetimibe as an effective adjunct to high-intensity statin therapy for patients...
Significant serum cystatin C and lipoprotein abnormalities found in type 2 diabetes patients with nephropathy: Study Medha Baranwal3 May 2023 9:45 AM ISTEthiopia: A recent study published in Frontiers in Endocrinology has revealed a significant serum cystatin C and lipoprotein in type 2 diabetes...
Astaxanthin lowers cholesterol and CVD risk in people with prediabetes and dyslipidemia Medha Baranwal6 April 2023 11:30 AM ISTUSA: A recent study published in Diabetes, Obesity and Metabolism has shown that astaxanthin, a natural antioxidant is a safe over-the-counter (OTC)...
